Patent · US Active

Steroid derivative FXR agonist

US10875888B2 · kind B2 · utility

2Cited by

0References

20Claims

0Family size

Assignee

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

Haiying He · Shanghai, CN
Hualing Xiao · Zhuqiao, CN
Peng Li · New York, US
Chunyan Du · Bedford, US
Zhi Luo · Taichung, TW
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jan 25, 2017
Grant date	Dec 29, 2020
Priority date	—
Expiry date	Apr 23, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J41/0094
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt thereof, and relates to applications thereof in the preparation of drugs for treating FXR related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.